Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


COUCHMAN JONATHAN Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/17/2020 SC 13D/A COUCHMAN JONATHAN reports a 17.8% stake in Enzon Pharmaceuticals, Inc.
08/26/2020 4 COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.
Txns: Sold 52,100 shares @ $0.1834, valued at $9.6k
Sold 25,000 shares @ $0.1913, valued at $4.8k
08/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/06/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/05/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/16/2020 SC 13D COUCHMAN JONATHAN reports a 16.6% stake in Enzon Pharmaceuticals, Inc.
03/31/2020 4/A COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.
Txns: Bought 19,709 shares @ $0.135, valued at $2.7k
Bought 2,678 shares @ $0.14, valued at $374.9
Bought 469,551 shares @ $0.14, valued at $65.7k
Bought 160,785 shares @ $0.14, valued at $22.5k
03/27/2020 4 COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.
Txns: Bought 19,709 shares @ $0.135, valued at $2.7k
Bought 2,678 shares @ $0.14, valued at $374.9
Bought 469,551 shares @ $0.14, valued at $65.7k
Bought 160,785 shares @ $0.14, valued at $22.5k
03/27/2020 SC 13G/A COUCHMAN JONATHAN reports a 16.6% stake in Enzon Pharmaceuticals, Inc.
02/14/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/09/2019 4 COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.
Txns: Bought 20,600 shares @ $0.255, valued at $5.3k
Bought 8,800 shares @ $0.2588, valued at $2.3k
Bought 67,200 shares @ $0.26, valued at $17.5k
Bought 100,000 shares @ $0.21, valued at $21k
Bought 100,000 shares @ $0.21, valued at $21k
Bought 2,500 shares @ $0.21, valued at $525
Bought 15,000 shares @ $0.2196, valued at $3.3k
Bought 40,050 shares @ $0.22, valued at $8.8k
Bought 42,450 shares @ $0.22, valued at $9.3k
Bought 450 shares @ $0.22, valued at $99
Bought 1,100 shares @ $0.22, valued at $242
01/09/2019 4 COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.
Txns: Bought 4,700 shares @ $0.26, valued at $1.2k
Bought 185,700 shares @ $0.26, valued at $48.3k
Bought 3,000 shares @ $0.26, valued at $780
Bought 33,500 shares @ $0.26, valued at $8.7k
Bought 55,000 shares @ $0.26, valued at $14.3k
Bought 4,000 shares @ $0.26, valued at $1k
Bought 20,200 shares @ $0.26, valued at $5.3k
Bought 50,000 shares @ $0.26, valued at $13k
Bought 5,500 shares @ $0.26, valued at $1.4k
Bought 1,000 shares @ $0.26, valued at $260
Bought 2,000 shares @ $0.26, valued at $520
04/13/2018 3 COUCHMAN JONATHAN (10% Owner) has filed a Form 3 on ENZON PHARMACEUTICALS, INC.
04/13/2018 SC 13G/A COUCHMAN JONATHAN reports a 10.6% stake in Enzon Pharmaceuticals, Inc.
05/24/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/28/2013 SC 13E3 Form SC 13E3 - Going private transaction by certain issuers
01/16/2013 SC 13D/A Xstelos Holdings, Inc. reports a 50.7% stake in Xstelos Holdings, Inc.
04/26/2012 4 COUCHMAN JONATHAN (President and CEO) has filed a Form 4 on Xstelos Holdings, Inc.
Txns: Acquired 11,063,578 shares @ $0
Acquired 1 options @ $0.35, valued at $0.4
04/26/2012 SC 13D Xstelos Holdings, Inc. reports a 50.7% stake in Xstelos Holdings, Inc.
04/23/2012 3 COUCHMAN JONATHAN (President and CEO) has filed a Form 3 on Xstelos Holdings, Inc.
02/05/2010 5 Form 5 - Annual statement of changes in beneficial ownership of securities
01/20/2010 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/25/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
06/26/2009 5 COUCHMAN JONATHAN (Director) has filed a Form 5 on GOLF TRUST OF AMERICA INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy